Rett syndrome

Molecular Syndromology

Volumn 2, Issue 3-5, 2011, Pages 113-127

  Smeets, E E J ^a   Pelc, K ^b   Dan, B ^b  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b HOP UNIV DES ENFANTS REINE FABIOLA   (Belgium)

Author keywords

MeCP2; Rett syndrome

Indexed keywords

METHYL CPG BINDING PROTEIN 2;

AGITATION; APRAXIA; ARTICLE; ATAXIA; BRUXISM; CHROMATIN CONDENSATION; CLINICAL ASSESSMENT; CYANOSIS; DNA METHYLATION; DYSAUTONOMIA; FOOT MALFORMATION; FRAMESHIFT MUTATION; GENETIC ASSOCIATION; GENETIC COUNSELING; GENETIC VARIABILITY; GENOTYPE PHENOTYPE CORRELATION; HUMAN; INTELLECTUAL IMPAIRMENT; KYPHOSCOLIOSIS; MICROCEPHALY; MISSENSE MUTATION; MULTIPLEX LIGATION DEPENDENT PROBE AMPLIFICATION; MUSCLE TONE; NOCICEPTION; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; POINT MUTATION; PRIORITY JOURNAL; RECURRENCE RISK; RETT SYNDROME; SEIZURE; SLEEP DEPRIVATION; STEREOTYPY; X CHROMOSOME INACTIVATION;

EID: 84860198398     PISSN: 16618769     EISSN: 16618777     Source Type: Journal    
DOI: 10.1159/000337637     Document Type: Article

References (90)

1. Amir RE, Van den Veyver IB, Wan M, Tran CQ, Francke U, Zoghbi HY: Rett syndrome is caused by mutations in X-linked MECP2 , encoding methyl-CpG-binding protein 2. Nat Genet 23: 185-188 (1999 (Pubitemid 29455390)
2. Archer H, Evans J, Leonard H, Colvin L, Ravine D, et al: Correlation between clinical severity in patients with Rett syndrome with p.R168X or p.T158M MECP2 mutation and the direction and degree of skewing of Xchromosome inactivation. J Med Genet 44: 148-52 (2007.
3. Armstrong DD: Neuropathology of Rett syndrome. MRDD Research Reviews 8: 72-76 (2002 (Pubitemid 34606516)
4. Armstrong DD, Kinney HC: The neuropathology of the Rett disorder, in Kerr A, Witt- Engerström I (eds): Rett Disorder and the Developing Brain. The Neuropathology of the Rett Disorder, pp 57-84 (Oxford University Press, Oxford 2001
5. Armstrong DD, Dunn JK, Antalffy B: Decreased dendritic branching in frontal, motor, limbic cortex in Rett syndrome compared with trisomy 21. J Neuropathol Exp Neurol 57: 1013-1017 (1998 (Pubitemid 28525447)
6. Bebbington A, Percy A, Christodoulou J, Ravine D, Ho G, et al: Updating the profile of C-terminal MECP2 deletions in Rett syndrome. J Med Genet 47: 242-248 (2010
7. Bourdon V, Philippe C, Labrune O, Amsallem D, Arnould C, Jonveaux P: A detailed analysis of the MECP2 gene: prevalence of recurrent mutations and gross rearrangements in Rett syndrome patients. Hum Genet 108: 43-50 (2001 (Pubitemid 32140541)
8. Brero A, Easwaran HP, Nowak D, Grunewald I, Cremer T, et al: Methyl CpG-binding proteins induce large-scale chromatin reorganization during terminal differentiation. J Cell Biol 169: 733-743 (2005 (Pubitemid 41002879)
9. Chahrour M, Zoghbi HY: The story of Rett syndrome: from clinic to neurobiology. Neuron 56: 422-437 (2007 (Pubitemid 350026269)
10. Chandler SP, Guschin D, Landsberger N, Wolffe AP: The methyl-CpG-binding transcriptional repressor MeCP2 stably associates with nucleosomal DNA. Biochemistry 38: 7008-7018 (1999
11. Chang Q, Khare G, Dani V, Nelson S, Jaenisch R: The disease progression of Mecp2 mutant mice is affected by the level of BDNF expression. Neuron 2006, 49, 341-348 (Pubitemid 43152236)
12. Chen W, Chang Q, Lin Y, Meissner A, West A, et al: Derepression of BDNF transcription involves calcium-dependent phosphorylation of MECP2. Science 302: 885 (2003
13. Clouaire T, Stancheva I: Methyl-CpG binding proteins: specialized transcriptional repressors or structural components of chromatin? Cell Mol Life Sci 65: 1509-1522 (2008
14. Collins AL, Levenson JM, Vilaythong AP, Richman R, Armstrong DL, et al: Mild overexpression of MeCP2 causes a progressive neurological disorder in mice. Hum Mol Genet 13: 2679-2689 (2004 (Pubitemid 39485416)
15. Dan B: Angelman syndrome: current understanding and research prospects. Epilepsia 50: 2331-2339 (2009
16. Dan B, Cheron B: Postural control in children with Rett syndrome or Angelman syndrome; in Hadders-Algra M, Brogren Carlberg E(eds): Posture: A Key Issue in Developmental Disorders, pp 148-169 (Mac Keith Press, London 2008
17. Elian M, de M Rudolf N: Observations on hand movements in Rett syndrome: a pilot study. Acta Neurol Scand 94: 212-214 (1996 (Pubitemid 26330361)
18. Ellaway C, Christodoulou J: Rett syndrome: clinical characteristics and recent genetic advances. Disabil Rehabil 23: 98-106 (2001 (Pubitemid 32218950)
19. Fehr S, Bebbington A, Nassar N, Downs J, Ronen GM, et al: Trends in the diagnosis of Rett syndrome in Australia. Pediatr Res 70: 313-319 (2011
20. Freilinger M, Bebbington A, Lanator I, De Klerk N, Dunkler D, et al: Survival with Rett syndrome: comparing Rett's original sample with data from the Australian Rett Syndrome Database. Dev Med Child Neurol 52: 962-965 (2010
21. Gabellini D, Green MR, Tupler R: When enough is enough: genetic diseases associated with transcriptional derepression. Curr Opin Genet Dev 14: 301-307 (2004 (Pubitemid 38686936)
22. Gaspard N, Vanderhaeghen P: From stem cells to neural networks: recent advances and perspectives for neurodevelopmental disorders. Dev Med Child Neurol 53: 13-17 (2011
23. Girard M, Couvert P, Carrie A, Tardieu M, Chelly J, et al: Parental origin of de novo MECP2 mutations in Rett syndrome. Eur J Hum Genet 9: 231-236 (2001 (Pubitemid 32241774)
24. Glaze DG, Percy AK, Motil KJ, Lane JB, Isaacs JS, et al: A study of the treatment of Rett syndrome with folate and betaine. J Child Neurol 24: 551-556 (2009
25. Guy J, Gan J, Selfridge J, Cobb S, Bird A: Reversal of neurological defects in a mouse model of Rett syndrome. Science 315: 1143-1147 (2007 (Pubitemid 46328028)
26. Hagberg B, Gillberg C: Rett variants-Rettoid phenotypes; in Hagberg B (ed): Rett Syndrome, Clinical and Biological Aspects, Clinics in Developmental Medicine vol. 127, pp 40-60 (MacKeith Press/Cambridge University Press, Cambridge 1993
27. Hagberg B, Aicardi J, Dias K, Ramos O: A progressive syndrome of autism, dementia, ataxia and loss of purposeful handuse in girls: Rett's syndrome: report of 35 cases. Ann Neurol 14: 471-479 (1983 (Pubitemid 13010048)
28. Hagberg B, Stenbom Y, Engerström IW: Head growth in Rett syndrome. Brain Dev 23 (suppl 1):S227-S229 (2001
29. Hagberg B, Hanefeld F, Percy A, Skjeldal O: An update on clinically applicable diagnostic criteria in Rett syndrome. Eur J Peadiatr Neurol 6: 293-297 (2002
30. Halbach N, Smeets E, van den Braak N, van Roozendaal K, Blok R, et al: Genotype-phenotype relationships as prognosticators in Rett syndrome should be handled with care in clinical practice. Am J Med Genet A 158A:340-350 (2012
31. Huppke P, Laccone F, Kramer N, Engel W, Hanefeld F: Rett syndrome: analysis of MECP2 and clinical characterization of 31 patients. Hum Mol Genet 9: 1369-1375 (2000 (Pubitemid 30312485)
32. Ishii T, Makita Y, Ogawa A, Amamiya S, Yamamoto M, et al: The role of different X-inactivation pattern on the variable clinical phenotype with Rett syndrome. Brain Dev 23 (suppl 1):S161-S164 (2001
33. Ishikawa A, Goto T, Narasaki M, Yokochi K, Kitahara H, Fukuyama Y: A new syndrome of progressive psychomotor retardation with peculiar stereotyped movements and autistic tendency: a report of three cases. Brain Dev 3: 258 (1978
34. Jugloff DG, Vandamme K, Logan R Visanji NP, Brotchie JM, Eubanks JH: Targeted delivery of a Mecp2 transgene to forebrain neurons improves the behavior of female Mecp2 -deficient mice. Hum Mol Genet 17: 1386-1396 (2008 (Pubitemid 351627335)
35. Julu PO, Witt Engerström I: Assessment of the maturity-related brainstem functions reveals the heterogeneous phenotypes and facilitates clinical management of Rett syndrome. Brain Dev 27 (suppl 1):S43-S53 (2005 (Pubitemid 41501609)
36. Julu PO, Kerr AM, Apartopoulos F, Al-Rawas S, Witt-Engerström I, et al: Characterisation of breathing and associated central autonomic dysfunction in the Rett disorder. Arch Dis Child 85: 29-37 (2001
37. Julu PO, Witt Engerström I, Hansen S, Apartopoulos F, Witt B, et al: Clinical update addressing the cardiorespiratory challenges in medicine posed by Rett syndrome: The Frösö Declaration. Lancet 371: 1981-1983 (2008
38. Katz DM, Dutschmann M, Ramirez JM, Hilaire G: Breathing disorders in Rett syndrome: progressive neurochemical dysfunction in the respiratory network after birth. Respir Physiol Neurobiol 168: 101-108 (2009
39. Kaufmann WE, Jarrar MH, Wang JS, Lee YJ, Reddy S, et al: Histone modifications in Rett syndrome lymphocytes: a preliminary evaluation. Brain Dev 27: 331-339 (2005 (Pubitemid 40991752)
40. Kerr AM: Rett syndrome British longitudinal study (1982-1990) and 1990 survey; in Roosendaal JJ (ed): Mental Retardation and Medical Care, pp 143-145 (Kerckbosch Publisher, Zeist 1992
41. Kerr A, Witt Engerström I: Rett Disorder and the Developing Brain (Oxford University Press, Oxford 2001
42. LaSalle JM, Goldstine J, Balmer D, Greco CM: Quantitative localization of heterogeneous methyl-CpG-binding protein 2 (MeCP2) expression phenotypes in normal and Rett syndrome brain by laser scanning cytometry. Hum Mol Genet 10: 1729-1740 (2001 (Pubitemid 32899090)
43. Laskawi R: The use of botulinum toxin in head and face medicine: an interdisciplinary field. Head Face Med 10: 4-5 (2008
44. Leonard H, Silberstein J, Falk R, Houwink-Manville I, Ellaway C, et al: Occurrence of Rett syndrome in boys. J Child Neurol 16: 333-338 (2001 (Pubitemid 32547297)
45. Lioy DT, Wu WW, Bissonnette JM: Autonomic dysfunction with mutations in the gene that encodes methyl-CpG-binding protein 2: insights into Rett syndrome. Auton Neurosci 161: 55-62 (2011
46. Martin R, Mogg AE, Heywood LA, Nitschke L, Burke JF: Aminoglycoside suppression at UAG, UAA and UGA codons in Escherichia coli and human tissue culture cells. Mol Gen Genet 217: 411-418 (1989 (Pubitemid 19165012)
47. Martinowich K, Hattori D, Wu H, Fouse S, He F, et al: DNA methylation-related chromatin remodeling in activity-dependent BDNF gene regulation. Science 302: 890 (2003
48. Moog U, Smeets E, van Roozendaal K, Schoenmakers S, Herbergs J, et al: Neurodevelopmental disorders in males related to the gene causing Rett syndrome in females (MECP2) . Eur J Paediatr Neurol 7: 5-12 (2003 (Pubitemid 36284838)
49. Motil KJ, Schultz RJ, Browning K, Trautwein L, Glaze DG: Oropharyngeal dysfunction and gastroesophageal dysmotility are present in girls and women with Rett syndrome. J Pediatr Gastroenterol Nutr 29: 31-37 (1999 (Pubitemid 30345824)
50. Nan X, Ng HH, Johnson CA, Laherty CD, Tur - ner BM, et al: Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature 393: 386-389 (1998 (Pubitemid 28269714)
51. Nectoux J, Bahi-Buisson N, Guellec I, Coste J, De Roux N, et al: The p.Val66Met polymorphism in the BDNF gene protects against early seizures in Rett syndrome. Neurology 70(22 Pt 2):2145-2151 (2008
52. Neul JL, Kaufmann WE, Glaze DG, Christodoulou J, Clarke AJ, et al: Rett syndrome: revised diagnostic criteria and nomenclature. Ann Neurol 68: 944-950 (2010
53. Nissenkorn A, Gak E, Vecksler M, Reznik H, Menascu S, Ben Zeev B: Epilepsy in Rett syndrome - the experience of a National Rett Center. Epilepsia 51: 1252-1258 (2010
54. Nomura Y, Segawa M: Motor symptoms of the Rett syndrome: abnormal muscle tone, posture, locomotion and stereotyped movement. Brain Dev 14 (suppl):S21-S28 (1992
55. Nomura Y, Segawa M, Higurashi M: Rett syndrome - an early catecholamine and indolamine deficient disorder? Brain Dev 7: 334-341 (1985 (Pubitemid 15239583)
56. Ogier M, Wang H, Hong E, Wang Q, Greenberg ME, Katz DM: Brain-derived neurotrophic factor expression and respiratory function improve after ampakine treatment in a mouse model of Rett syndrome. J Neurosci 27: 10912-10917 (2007 (Pubitemid 47535875)
57. Pelc K, Dan B: Postural cortical myoclonus during gait in Rett syndrome. Epilepsy Behav 16: 188 (2009
58. Philippe C, Villard L, De Roux N, Raynaud M, Bonnefond JP, et al: Spectrum and distribution of MECP2 mutations in 424 Rett syndrome patients: a molecular update. Eur J Med Genet 49: 9-18 (2006 (Pubitemid 43213195)
59. Ramocki M, Tavyev Y, Peters S: The MECP2 uplication syndrome. Am J Med Genet A 152: 1079-1088 (2010
60. Renieri A, Meloni I, Longo I, Ariani F, Mari F, et al: Rett syndrome: the complex nature of a monogenic disease. J Mol Med 81: 346-354 (2003 (Pubitemid 36783238)
61. Rett A: Über ein eigenartiges hirnatrophisches Syndrom bei Hyperammonämie im Kindesalter. Wien Med Wochenschr 116: 723-728 (1966
62. Rett A: Cerebral Atrophy associated with hyperammonaemia, in Vinklen PJ, Bruyn GW (eds): Handbook of Clinical Neurology, vol. 29, pp 305-329 (North Holland publishing company, Amsterdam 1977
63. Rohdin M, Fernell E, Eriksson M, Albåge M, Lagercrantz H, Katz-Salamon M: Disturbances in cardiorespiratory function during day and night in Rett syndrome. Pediatr Neurol 37: 338-344 (2007 (Pubitemid 47575825)
64. Samaco RC, Fryer JD, Ren J, Fyffe S, Chao HT, et al: A partial loss of function allele of methyl- CpG-binding protein predicts a human neurodevelopmental syndrome. Hum Mol Genet 17: 1718-1727 (2008 (Pubitemid 351791498)
65. Schanen NC, Dahle EJ, Capozzoli F, Holm VA, Zoghbi HY, Francke U: A new Rett syndrome family consistent with X-linked inheritance expands the X chromosome exclusion map. Am J Hum Genet 61: 634-641 (1997 (Pubitemid 27418405)
66. Schollen E, Smeets E, Deflem E, Fryns JP, Matthijs G: Gross rearrangements in the MECP2 gene in three patients with Rett syndrome: implications for routine diagnosis of Rett syndrome. Hum Mut 22: 116-120 (2003 (Pubitemid 36950808)
67. Schultz R, Glaze D, Motil K, Hebert D, Percy A: Hand and foot growth failure in Rett syndrome. J Child Neurol 13: 71-74 (1998 (Pubitemid 28155113)
68. Shahbazian M, Young J, Yuva-Paylor L, Spencer C, Antalffy B, et al: Mice with truncated MeCP2 recapitulate many Rett syndrome features and display hyperacetylation of histone H3. Neuron 35: 243-254 (2002 (Pubitemid 34876728)
69. Smeets EE, Schrander-Stumpel CT: Rett Syndrome, in Cassidy S, Allanson J (eds): Management of Genetic Syndromes, 3rd ed, pp 677-691 (John Wiley & Sons Inc., Hoboken, NJ 2010
70. Smeets E, Schollen E, Moog U, Matthijs G, Herbergs J, et al: Rett Syndrome in adolescent and adult females: clinical and molecular genetic findings. Am J Med Gen 122A:227-233 (2003 (Pubitemid 37152868)
71. Smeets E, Terhal P, Casaer P, Peters A, Midro A, et al: Rett syndrome in females with CTS hot spot deletions: a disorder profile. Am J Med Genet A 132A:117-120 (2005 (Pubitemid 40093317)
72. Smeets E, Julu P, van Waardenburg D, Engerström I, Hansen S, et al: Management of a severe forceful breather with Rett syndrome using carbogen. Brain Dev 28: 625-632 (2006 (Pubitemid 44485955)
73. Smeets EE, Chenault M, Curfs LM, Schrander- Stumpel CT, Frijns JP: Rett syndrome and long-term disorder profile. Am J Med Genet A 149A:199-205 (2009
74. Steffenburg U, Hagberg G, Hagberg B: Epilepsy in a representative series of Rett syndrome. Acta Paediatr 90: 34-39 (2001 (Pubitemid 32147224)
75. Tao J, Van Esch H, Hagedorn-Greiwe M, Hoffmann K, Moser B, et al: Mutations in the X-linked cyclin-dependent kinase-like 5 (CDKL5/STK9) gene are associated with severe neurodevelopmental retardation. Am J Hum Genet 75: 1149-1154 (2004 (Pubitemid 39532084)
76. Tropea D, Giacometti E, Wilson NR, Beard C, McCurry C, et al: Partial reversal of Rett syndrome-like symptoms in MeCP2 mutant mice. Proc Natl Acad Sci USA 106: 2029-2034 (2009
77. Van Esch H, Bauters M, Ignatius J, Jansen M, Raynaud M, et al: Duplication of the MECP2 region is a frequent cause of severe mental retardation and progressive neurological symptoms in males. Am J Hum Genet 77: 442-453 (2005 (Pubitemid 41192650)
78. Villard J: MECP2 mutations in males. J Med Genet 44: 417-423 (2007
79. Wan M, Zhao K, Francke U: MECP2 truncating mutations cause histone H4 hyperacetylation in Rett syndrome. Hum Mol Genet 10: 1085-1092 (2001 (Pubitemid 32447786)
80. Wang H, Chan SA, Ogier M, Hellard D, Wang Q, et al: Dysregulation of brain derived neurotrophic factor expression and neurosecretory function in Mecp2 null mice. J Neurosci 26: 10911-10915 (2006
81. Weese-Mayer DE, Lieske SP, Boothby CM, Kenny AS, Bennett HL, et al: Autonomic nervous system dysregulation: breathing and heart rate perturbation during wakefulness in young girls with Rett syndrome. Pediatr Res 60: 443-449 (2006 (Pubitemid 44427598)
82. Williams CA, Driscoll DJ, Dagli AI: Clinical and genetic aspects of Angelman syndrome. Genet Med 12: 385-395 (2010
83. Witt Engerström I: Rett Syndrome in Sweden. Neurodevelopment - disability - pathophysiology. Acta Paediatr Scand Suppl 369: 1-60 (1990
84. Yaron Y, Ben Zeev B, Shomrat R, Bercovich D, Naiman T, Orr-Urtreger A: MECP2 mutations in Israel: implications for molecular analysis, genetic counseling and prenatal diagnosis in Rett syndrome. Hum Mutat 20: 323-324 (2002
85. Yasui DH, Peddada S, Bieda MC, Vallero RO, Hogart A, et al: Integrated epigenomic analyses of neuronal MeCP2 reveal a role for long-range interaction with active genes. Proc Natl Acad Sci USA 104: 19416-19321 (2007
86. Yntema HG, Oudakker AR, Kleefstra T, Hamel BC, van Bokhoven H, et al: In-frame deletion in MECP2 causes mild nonspecific mental retardation. Am J Med Genet 107: 81-83 (2002 (Pubitemid 34003365)
87. Zoghbi HY, Percy AK, Schulz RJ, Fill C: Patterns of X chromosome inactivation in the Rett syndrome. Brain Dev 12: 131-135 (1990 (Pubitemid 20119245)
88. Zweier C, Peippo MM, Hoyer J, Sousa S, Bottani A, et al: Haploinsufficiency of TCF4 causes syndromal mental retardation with intermittent hyperventilation (Pitt-Hopkins syndrome). Am J Hum Genet 80: 994-1001 (2007 (Pubitemid 46668469)
89. Zweier C, Sticht H, Bijlsma EK, Clayton-Smith J, Boonen SE, et al: Further delineation of Pitt- Hopkins syndrome: phenotypic and genotypic description of 16 novel patients. J Med Genet 45: 738-744 (2008
90. Zweier C, de Jong EK, Zweier M, Orrico A, Ousager LB, et al: CNTNAP2 and NRXN1 are mutated in autosomal-recessive Pitt-Hopkins- like mental retardation and determine the level of a common synaptic protein in Drosophila. Am J Hum Genet 85: 655-666 (2009